These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 25944465)
1. Downregulation of miR-375 in aldosterone-producing adenomas promotes tumour cell growth via MTDH. He J; Cao Y; Su T; Jiang Y; Jiang L; Zhou W; Zhang C; Wang W; Ning G Clin Endocrinol (Oxf); 2015 Oct; 83(4):581-9. PubMed ID: 25944465 [TBL] [Abstract][Full Text] [Related]
2. MiR-193a-3p functions as a tumour suppressor in human aldosterone-producing adrenocortical adenoma by down-regulating CYP11B2. Zhang G; Zou X; Liu Q; Xie T; Huang R; Kang H; Lai C; Zhu J Int J Exp Pathol; 2018 Apr; 99(2):77-86. PubMed ID: 29665181 [TBL] [Abstract][Full Text] [Related]
3. miRNA-203 Modulates Aldosterone Levels and Cell Proliferation by Targeting Wnt5a in Aldosterone-Producing Adenomas. Peng KY; Chang HM; Lin YF; Chan CK; Chang CH; Chueh SJ; Yang SY; Huang KH; Lin YH; Wu VC; Wu KD J Clin Endocrinol Metab; 2018 Oct; 103(10):3737-3747. PubMed ID: 30085132 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-433 inhibits cervical cancer progression by directly targeting metadherin to regulate the AKT and β-catenin signalling pathways. Liang C; Ding J; Yang Y; Deng L; Li X Oncol Rep; 2017 Dec; 38(6):3639-3649. PubMed ID: 29130111 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA expression patterns associated with hyperfunctioning and non-hyperfunctioning phenotypes in adrenocortical adenomas. Velázquez-Fernández D; Caramuta S; Özata DM; Lu M; Höög A; Bäckdahl M; Larsson C; Lui WO; Zedenius J Eur J Endocrinol; 2014 Apr; 170(4):583-91. PubMed ID: 24446485 [TBL] [Abstract][Full Text] [Related]
6. Lower expression of the TWIK-related acid-sensitive K+ channel 2 (TASK-2) gene is a hallmark of aldosterone-producing adenoma causing human primary aldosteronism. Lenzini L; Caroccia B; Campos AG; Fassina A; Belloni AS; Seccia TM; Kuppusamy M; Ferraro S; Skander G; Bader M; Rainey WE; Rossi GP J Clin Endocrinol Metab; 2014 Apr; 99(4):E674-82. PubMed ID: 24285684 [TBL] [Abstract][Full Text] [Related]
7. MiR-1297 suppresses pancreatic cancer cell proliferation and metastasis by targeting MTDH. Chen Z; Ma Y; Pan Y; Zhu H; Yu C; Sun C Mol Cell Probes; 2018 Aug; 40():19-26. PubMed ID: 29908229 [TBL] [Abstract][Full Text] [Related]
8. MiR-153 inhibits epithelial-mesenchymal transition by targeting metadherin in human breast cancer. Li W; Zhai L; Zhao C; Lv S Breast Cancer Res Treat; 2015 Apr; 150(3):501-9. PubMed ID: 25794773 [TBL] [Abstract][Full Text] [Related]
9. Local Control of Aldosterone Production and Primary Aldosteronism. Lalli E; Barhanin J; Zennaro MC; Warth R Trends Endocrinol Metab; 2016 Mar; 27(3):123-131. PubMed ID: 26803728 [TBL] [Abstract][Full Text] [Related]
10. Elevated expression of luteinizing hormone receptor in aldosterone-producing adenomas. Saner-Amigh K; Mayhew BA; Mantero F; Schiavi F; White PC; Rao CV; Rainey WE J Clin Endocrinol Metab; 2006 Mar; 91(3):1136-42. PubMed ID: 16332935 [TBL] [Abstract][Full Text] [Related]
11. Identification of novel molecular targets regulated by tumor suppressive miR-375 induced by histone acetylation in esophageal squamous cell carcinoma. Isozaki Y; Hoshino I; Nohata N; Kinoshita T; Akutsu Y; Hanari N; Mori M; Yoneyama Y; Akanuma N; Takeshita N; Maruyama T; Seki N; Nishino N; Yoshida M; Matsubara H Int J Oncol; 2012 Sep; 41(3):985-94. PubMed ID: 22752059 [TBL] [Abstract][Full Text] [Related]
12. Down-regulation of D2 dopamine receptor and increased protein kinase Cmu phosphorylation in aldosterone-producing adenoma play roles in aldosterone overproduction. Chang HW; Chu TS; Huang HY; Chueh SC; Wu VC; Chen YM; Hsieh BS; Wu KD J Clin Endocrinol Metab; 2007 May; 92(5):1863-70. PubMed ID: 17299068 [TBL] [Abstract][Full Text] [Related]
13. Teratocarcinoma-derived growth factor-1 is upregulated in aldosterone-producing adenomas and increases aldosterone secretion and inhibits apoptosis in vitro. Williams TA; Monticone S; Morello F; Liew CC; Mengozzi G; Pilon C; Asioli S; Sapino A; Veglio F; Mulatero P Hypertension; 2010 Jun; 55(6):1468-75. PubMed ID: 20385969 [TBL] [Abstract][Full Text] [Related]
14. microRNA-22 acts as a metastasis suppressor by targeting metadherin in gastric cancer. Tang Y; Liu X; Su B; Zhang Z; Zeng X; Lei Y; Shan J; Wu Y; Tang H; Su Q Mol Med Rep; 2015 Jan; 11(1):454-60. PubMed ID: 25323629 [TBL] [Abstract][Full Text] [Related]
15. Elementary studies on elevated steroidogenic factor-1 expression in aldosterone-producing adenoma. Hu D; Ouyang J; Wu Z; Shi T; Wang B; Ma X; Li H; Wang S; Zhang X Urol Oncol; 2012; 30(4):457-62. PubMed ID: 20875752 [TBL] [Abstract][Full Text] [Related]
16. Mast cell hyperplasia is associated with aldosterone hypersecretion in a subset of aldosterone-producing adenomas. Duparc C; Moreau L; Dzib JF; Boyer HG; Tetsi Nomigni M; Boutelet I; Boulkroun S; Mukai K; Benecke AG; Amar L; Gobet F; Meatchi T; Plouin PF; Zennaro MC; Louiset E; Lefebvre H J Clin Endocrinol Metab; 2015 Apr; 100(4):E550-60. PubMed ID: 25599386 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881 [TBL] [Abstract][Full Text] [Related]
18. Significance of dysregulated metadherin and microRNA-375 in head and neck cancer. Hui AB; Bruce JP; Alajez NM; Shi W; Yue S; Perez-Ordonez B; Xu W; O'Sullivan B; Waldron J; Cummings B; Gullane P; Siu L; Liu FF Clin Cancer Res; 2011 Dec; 17(24):7539-50. PubMed ID: 22031094 [TBL] [Abstract][Full Text] [Related]
19. Microribonucleic acid-21 increases aldosterone secretion and proliferation in H295R human adrenocortical cells. Romero DG; Plonczynski MW; Carvajal CA; Gomez-Sanchez EP; Gomez-Sanchez CE Endocrinology; 2008 May; 149(5):2477-83. PubMed ID: 18218696 [TBL] [Abstract][Full Text] [Related]